Kit Simpson to Costs and Cost Analysis
This is a "connection" page, showing publications Kit Simpson has written about Costs and Cost Analysis.
Connection Strength
1.091
-
The Monetary Cost of Sexual Assault to Privately Insured US Women in 2013. Am J Public Health. 2017 06; 107(6):983-988.
Score: 0.541
-
Economic and health-related quality-of-life (HRQoL) comparison of lopinavir/ritonavir (LPV/r) and atazanavir plus ritonavir (ATV+RTV) based regimens for antiretroviral therapy (ART)-na?ve and -experienced United Kingdom patients in 2011. J Med Econ. 2012; 15(4):796-806.
Score: 0.097
-
Timing of elective repeat cesarean delivery at term and neonatal outcomes: a cost analysis. Am J Obstet Gynecol. 2010 Jun; 202(6):632.e1-6.
Score: 0.083
-
Cost-effectiveness of extended adjuvant rituximab for US patients aged 65-70 years with follicular lymphoma in second remission. Clin Lymphoma Myeloma. 2008 Jun; 8(3):166-70.
Score: 0.073
-
Cost effectiveness of lopinavir/ritonavir compared with atazanavir plus ritonavir in antiretroviral-experienced patients in the US. Clin Drug Investig. 2007; 27(7):443-52.
Score: 0.066
-
Comorbid depression is associated with increased health care use and expenditures in individuals with diabetes. Diabetes Care. 2002 Mar; 25(3):464-70.
Score: 0.047
-
Management of Pediatric Isolated Skull Fractures: A Decision Tree and Cost Analysis on Emergency Department Disposition Strategies. Pediatr Emerg Care. 2018 Jun; 34(6):403-408.
Score: 0.037
-
Cost-effectiveness of mandatory compared with voluntary screening for human immunodeficiency virus in pregnancy. Obstet Gynecol. 1998 Feb; 91(2):174-81.
Score: 0.036
-
Idiopathic thrombocytopenia purpura: Treatment patterns and an analysis of cost associated with intravenous immunoglobulin and anti-D therapy. Semin Hematol. 1998 Jan; 35(1 Suppl 1):58-64.
Score: 0.035
-
Frequency, cost, and risk factors of readmissions among severe sepsis survivors. Crit Care Med. 2015 Apr; 43(4):738-46.
Score: 0.029
-
Drivers of costs associated with reperfusion therapy in acute stroke: the Interventional Management of Stroke III Trial. Stroke. 2014 Jun; 45(6):1791-8.
Score: 0.028
-
Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing. Am J Gastroenterol. 2000 Nov; 95(11):3250-8.
Score: 0.011
-
Estimating the cost effectiveness of atovaquone versus intravenous pentamidine in the treatment of mild-to-moderate Pneumocystis carinii pneumonia. Pharmacoeconomics. 1996 Jun; 9(6):525-34.
Score: 0.008